Patent ID: 11896646
Assignee: NAMMI THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 1:
2. The TLR prodrug of claim 1, wherein the lipid moiety comprises a lipid selected from the group consisting of cholesterol, the sodium salt of 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol), the sodium salt of 1,2-dimyristoyl-sn-glycero-3-phospho-(1′-rac-glycerol), 1-decanoyl-2-hydroxy-sn-glycero-3-phosphocholine, the sodium salt of 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol), soy L-α-lysophosphatidylcholine, the sodium salt of 1,2-dilauroyl-sn-glycero-3-phospho-(1′rac-glycerol), the ammonium salt of 1,2-dipalmitoyl-sn-glycero-3-phospho((ethyl-1′,2′, 3′-triazole)triethyleneglycolmannose, N-palmitoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]} and monophosphoryl Lipid A.